Purchase Order W911QY24P0008
Award Date 12/14/23
Potential Completion Date 6/13/24
Potential Value $197K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- This is a $167,496.80 STTR Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the minority-owned small business Zymeron Corporation. The contract is for research and development of innovative biotechnology solutions, including technologies related to protein degradation, antibacterials, antivirals, and drug delivery systems. Zymeron has experience providing medical research, engineering services, IT solutions, and biotech...
- This is a $167,495.16 firm fixed-price contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Zymeron Corporation, a minority-owned small business research and development firm, under the Small Business Innovation Research (SBIR) program. The contract supports Phase I research and development of small molecule metal chelate cap-endo inhibitors as broad-spectrum antiviral treatments targeting bunyaviruses. The research is being...
- This is a $299,998.00 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Zymeron Corporation, a Minority Owned small business, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development related to "Combinatory Treatment Modalities Utilizing Radiation to Locally Activate or Release Systemically Delivered Therapeutics", as part of SBIR Topic...
- This $3 million firm-fixed-price contract was awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business, under the DHA's Small Business Innovation Research (SBIR) program. The contract supports the development of a "Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics", aligning with the DHA's mission to provide innovative medical technologies for military healthcare. The contract has an ultimate completion date of...
- This contract is a $249,999.09 Small Business Innovation Research (SBIR) Phase I award from the Department of the Army Medical Command to Zymeron Corporation, a minority-owned biotechnology company based in Research Triangle Park, North Carolina. The award supports the research and development of a "Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." As a prime contractor, Zymeron has experience providing medical research, engineering services, IT...
- The U.S. government's Medical Command (MEDCOM) awarded a $1,100,000.00 firm-fixed-price Small Business Innovation Research (SBIR) Phase II contract to Zymeron Corporation, a minority-owned small business, for the research and development of "Novel Antibiotics Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." The contract, which has a completion date of November 10, 2024, is focused on developing innovative solutions to address the challenge of antibiotic-resistant...
- The Zymeron Corporation was awarded a $299,998 firm fixed price Small Business Innovation Research Program Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for the research and development of a rapid point-of-care diagnostic test for histoplasmosis. This award falls under the larger SBIR solicitation issued by NIH and CDC seeking proposals in areas including cancer immunotherapy manufacturing, opioid withdrawal...
- This is a $1,484,722.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract was awarded under DARPA's Small Business Innovation Research (SBIR) program, Phase II, for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology. This Phase II award builds upon earlier SBIR work and is...